Evidence map›Paper›PMID 42493813›Full record

ReviewCritical care (London, England)2026

Pressure-targeted neurocritical care at the bedside: the emerging role of transcranial doppler.

Rafael Hortêncio Melo, Chiara Robba

Abstract readReview
In one paragraph

Review in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rafael Hortêncio MeloFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. rafaelmeloufc@yahoo.com.br.
Chiara RobbaAnaesthesia and Intensive Care, IRCCS Policlinico San Martino, Genova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Management of acute brain injury (ABI) focuses on maintaining cerebral perfusion pressure through systemic blood pressure optimization. However, traditional approaches relying on fixed pressure thresholds may not fully capture the complex interaction between systemic hemodynamics, cerebrovascular resistance, and cerebral autoregulation. Transcranial Doppler (TCD) ultrasonography offers a noninvasive bedside method to assess cerebral blood flow velocity patterns and their response to hemodynamic interventions. Doppler-derived parameters such as diastolic flow velocity (FVd) and pulsatility index (PI) provide physiological information that may help interpret the relationship between systemic arterial pressure and cerebral circulation. Observing how these signals change during controlled adjustments of mean arterial pressure may allow clinicians to identify pressure ranges in which cerebral perfusion appears more favorable for an individual patient. Importantly, TCD findings should not be interpreted in isolation but integrated with systemic hemodynamic assessment, including cardiac output, fluid responsiveness, and the underlying mechanism of hypotension. When used within a multimodal monitoring strategy, TCD may serve as a practical physiological tool to complement traditional neurocritical care monitoring. This viewpoint discusses the physiological rationale, potential clinical applications, and current limitations of Doppler-guided blood pressure targeting in patients with ABI.

Indexed as

Blood PressureBrain InjuriesCritical CareUltrasonography, Doppler, TranscranialBlood Flow VelocityCerebrovascular CirculationHemodynamicsHumansPoint-of-Care SystemsCerebral perfusionNeurocritical careTranscranial doppler

Identifiers

PMID42493813
PMCPMC13393723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.